BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17719191)

  • 1. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics.
    Zhang HY; Tang X; Li HY; Liu XL
    Int J Pharm; 2008 Feb; 348(1-2):70-9. PubMed ID: 17719191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of nimodipine-loaded lipid microspheres.
    Yu J; He HB; Tang X
    J Pharm Pharmacol; 2006 Nov; 58(11):1429-35. PubMed ID: 17132204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral formulation of larotaxel lipid microsphere tackling poor solubility and chemical instability.
    Teng F; Yang H; Li G; Lin X; Zhang Y; Tang X
    Int J Pharm; 2014 Jan; 460(1-2):212-9. PubMed ID: 24184034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
    Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
    J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
    Zhang WL; Liu JP; Liu XX; Chen ZQ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A less irritant norcantharidin lipid microspheres: formulation and drug distribution.
    Lixin W; Haibing H; Xing T; Ruiying S; Dawei C
    Int J Pharm; 2006 Oct; 323(1-2):161-7. PubMed ID: 16828998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on hypersensitivity and pharmacokinetics of paclitaxel microemulsion].
    He L; Wang GL; Zhang Q
    Yao Xue Xue Bao; 2003 Mar; 38(3):227-30. PubMed ID: 12830723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of less-painful clarithromycin lipid microspheres.
    LingHao Q; Wei L
    Arch Pharm Res; 2007 Oct; 30(10):1336-43. PubMed ID: 18038913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion.
    Shi S; Chen H; Cui Y; Tang X
    Int J Pharm; 2009 May; 373(1-2):147-55. PubMed ID: 19429300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and evaluation of clarithromycin emulsion for injection].
    Qin LH; Tang X
    Yao Xue Xue Bao; 2006 Oct; 41(10):945-9. PubMed ID: 17184111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of intravenous lipid emulsion of vinorelbine based on drug-phospholipid complex technique.
    Li Y; Jin W; Yan H; Liu H; Wang C
    Int J Pharm; 2013 Sep; 454(1):472-7. PubMed ID: 23806812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
    You J; Wan F; de Cui F; Sun Y; Du YZ; Hu FQ
    Int J Pharm; 2007 Oct; 343(1-2):270-6. PubMed ID: 17706383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution.
    Wei L; Marasini N; Li G; Yong CS; Kim JO; Quan Q
    Int J Pharm; 2012 Nov; 437(1-2):203-12. PubMed ID: 22944305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.
    Press RR; Buckle T; Beijnen JH; van Tellingen O
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):819-25. PubMed ID: 16163538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
    Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
    Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
    Maurya L; Singh S; Rajamanickam VM; Narayan G
    Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours.
    Bourgeois H; Vermorken J; Dark G; Jones A; Fumoleau P; Stupp R; Tourani J; Brain E; Nguyen L; Lefresne F; Puozzo C
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):407-13. PubMed ID: 17541591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats.
    Lu Y; Zhang Y; Yang Z; Tang X
    Int J Pharm; 2009 Jan; 366(1-2):160-9. PubMed ID: 18835427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.